See more : Twitter, Inc. (TWR.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Marker Therapeutics, Inc. (MRKR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Marker Therapeutics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Boozt AB (publ) (BOOZT.ST) Income Statement Analysis – Financial Results
- UA Multimedia, Inc. (UAMM) Income Statement Analysis – Financial Results
- Leonardo S.p.a. (FINMF) Income Statement Analysis – Financial Results
- Mountain Valley MD Holdings Inc. (MVMDF) Income Statement Analysis – Financial Results
- Alveen S.A. (MLALV.PA) Income Statement Analysis – Financial Results
Marker Therapeutics, Inc. (MRKR)
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.31M | 9.00M | 1.24M | 466.79K | 213.19K | 205.99K | 183.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.05K | 120.72K |
| Cost of Revenue | 10.42M | 3.68M | 3.16M | 18.88M | 12.76M | 124.00M | 5.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.63K | 38.60K |
| Gross Profit | -7.11M | 5.32M | -1.92M | -18.41M | -12.55M | -123.79M | -5.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.42K | 82.12K |
| Gross Profit Ratio | -214.60% | 59.13% | -154.70% | -3,944.85% | -5,887.41% | -60,094.84% | -2,768.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 89.50% | 68.03% |
| Research & Development | 10.42M | 26.14M | 27.79M | 18.88M | 12.76M | 124.00M | 5.25M | 3.80M | 1.71M | 189.00K | 661.63K | 1.06M | 203.73K | 290.05K | 93.04K | 182.34K | 425.57K | 173.17K | 248.36K | 1.04M | 1.73M | 833.59K | 0.00 | 341.19K | 294.92K |
| General & Administrative | 7.48M | 12.82M | 12.92M | 10.47M | 9.98M | 24.38M | 6.41M | 4.69M | 4.45M | 3.18M | 2.00M | 4.42M | 2.43M | 3.65M | 4.10M | 1.31M | 2.08M | 708.71K | 593.67K | 1.61M | 4.01M | 1.41M | 379.86K | 1.13M | 834.02K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.48M | 12.82M | 12.92M | 10.47M | 9.98M | 24.38M | 6.41M | 4.69M | 4.45M | 3.18M | 2.00M | 4.42M | 2.43M | 3.65M | 4.10M | 1.31M | 2.08M | 708.71K | 593.67K | 1.61M | 4.01M | 1.41M | 379.86K | 1.13M | 834.02K |
| Other Expenses | 0.00 | -232.97K | -2.41M | 0.00 | 0.00 | 116.05M | -183.06K | 1.83K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.74K | 7.48K | 5.97K | 6.37K | 147.53K | 37.45K | 42.37K | 40.77K | 0.00 | 20.64K | 17.71K |
| Operating Expenses | 17.89M | 38.96M | 40.72M | 29.35M | 22.74M | 148.38M | 11.48M | 8.26M | 6.16M | 3.37M | 2.66M | 5.48M | 2.64M | 3.94M | 4.19M | 1.50M | 2.51M | 888.25K | 989.56K | 2.68M | 5.78M | 2.28M | 379.86K | 1.49M | 1.15M |
| Cost & Expenses | 17.89M | 38.96M | 40.72M | 29.35M | 22.74M | 148.38M | 11.48M | 8.26M | 6.16M | 3.37M | 2.66M | 5.48M | 2.64M | 3.94M | 4.19M | 1.50M | 2.51M | 888.25K | 989.56K | 2.68M | 5.78M | 2.28M | 379.86K | 1.49M | 1.19M |
| Interest Income | 539.16K | 248.06K | 5.70K | 148.74K | 1.08M | 253.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.81K | 0.00 | 0.00 | 0.00 | 3.96K | 0.00 | 0.00 | 125.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.93K | 575.54K | 1.76M | 745.07K | 679.33K | 1.24M | 1.19M | 778.18K | 1.38M | 446.60K | 116.82K | 0.00 | -5.78M | -2.28M | -379.86K | 0.00 | 0.00 |
| Depreciation & Amortization | 2.79M | 3.68M | 3.16M | 1.08M | 286.58K | 148.17M | 11.48M | 8.49M | -27.90M | -26.94M | -466.28K | 1.11M | 1.29M | 93.84K | 3.74K | 7.48K | 5.97K | 6.37K | 71.51K | 37.45K | 42.37K | 40.89K | -4.68K | 20.64K | 17.71K |
| EBITDA | -11.79M | -19.79M | -36.32M | -27.63M | -22.03M | -147.97M | -11.30M | 6.04M | -34.06M | -30.31M | -3.78M | -5.58M | 0.00 | -3.85M | -3.27M | -1.41M | -2.51M | -851.42K | -838.07K | -2.65M | -5.74M | -2.24M | -379.86K | -457.20K | -1.05M |
| EBITDA Ratio | -356.14% | -291.69% | -2,924.62% | -5,964.44% | -10,441.30% | -71,910.65% | -6,543.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -6,476.07% | -815.17% |
| Operating Income | -14.58M | -29.95M | -39.48M | -28.89M | -22.53M | -148.17M | -11.66M | -8.49M | -6.16M | -3.37M | -3.31M | -6.22M | -2.64M | -3.94M | -5.38M | -2.28M | -2.51M | -888.25K | -989.56K | -2.68M | -5.78M | -2.28M | -379.86K | -1.47M | -1.06M |
| Operating Income Ratio | -440.37% | -332.56% | -3,179.32% | -6,188.25% | -10,567.28% | -71,930.07% | -6,371.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,857.63% | -881.85% |
| Total Other Income/Expenses | 539.16K | 15.09K | -2.40M | 179.74K | 1.10M | 213.72K | 497.87K | 6.04M | -27.91M | -27.51M | -2.87M | -373.57K | 607.92K | -1.15M | -268.53K | -695.52K | -1.38M | -416.14K | 29.69K | 0.00 | 0.00 | 0.00 | -4.68K | 460.51K | -62.80K |
| Income Before Tax | -14.04M | -29.93M | -41.88M | -28.71M | -21.43M | -147.96M | -10.98M | -2.46M | -34.07M | -30.88M | -5.53M | -5.86M | -2.03M | -5.09M | -4.46M | -2.20M | -3.89M | -1.30M | -989.56K | -2.68M | -5.78M | -2.28M | -384.54K | -1.29M | -1.13M |
| Income Before Tax Ratio | -424.09% | -332.40% | -3,372.68% | -6,149.74% | -10,050.92% | -71,826.32% | -5,999.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,156.80% | -933.87% |
| Income Tax Expense | 3.68K | -15.09K | -5.70K | -179.74K | -1.10M | -213.72K | -680.93K | -6.04M | 27.90M | 26.94M | 466.28K | -1.11M | -1.29M | -93.84K | 4.46M | 2.20M | 3.89M | 1.30M | 989.56K | 2.68M | 5.78M | 2.28M | 384.54K | 1.29M | 1.13M |
| Net Income | -14.05M | -29.92M | -41.87M | -28.53M | -20.33M | -147.96M | -10.98M | -2.46M | -34.07M | -30.88M | -5.53M | -5.86M | -2.03M | -5.09M | -4.46M | -2.20M | -3.89M | -1.30M | -989.56K | -2.68M | -5.78M | -2.28M | -384.54K | -1.29M | -1.13M |
| Net Income Ratio | -424.20% | -332.23% | -3,372.22% | -6,111.23% | -9,534.57% | -71,826.32% | -5,999.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,156.80% | -933.87% |
| EPS | -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.50 | -11.62 | -3.56 | -93.02 | -239.63 | -584.40 | -1.07K | -529.47 | -1.54K | -1.40K | -1.12K | -2.24K | -1.30M | -989.56K | -2.68M | -5.78M | -2.28M | -384.54K | -1.29M | -1.13M |
| EPS Diluted | -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.50 | -11.62 | -3.31 | -93.02 | -239.63 | -584.40 | -1.07K | -529.47 | -1.54K | -1.40K | -1.12K | -2.24K | -1.30M | -989.56K | -2.68M | -5.78M | -2.28M | -384.54K | -1.29M | -1.13M |
| Weighted Avg Shares Out | 8.81M | 8.35M | 7.65M | 4.70M | 4.56M | 1.91M | 945.35K | 688.99K | 366.23K | 128.88K | 9.47K | 5.46K | 3.83K | 3.32K | 3.20K | 1.95K | 1.73K | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Weighted Avg Shares Out (Dil) | 8.81M | 8.35M | 7.65M | 4.70M | 4.56M | 1.91M | 945.35K | 742.10K | 366.23K | 128.88K | 9.47K | 5.46K | 3.83K | 3.32K | 3.20K | 1.95K | 1.73K | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Going to Primark but not class? MPs' fury at teaching unions 'blocking' schools reopening
MPS have reacted in fury and blasted teaching unions for running a "disgraceful political campaign" which have left parents fearful of sending their children back to school - with one highlighting how children will be allowed to go into Primark...
Schools can't fully open in September under current distance rules, unions warn
Teachers' leaders called for public buildings to be taken over for extra classrooms, and warned 'blended' learning may still be necessary - as they demanded a plan from the government
Starmer refuses THREE TIMES to say it's safe for kids to go back to school
Sir Keir Starmer today refused three times to say if it’s safe for kids to go back to school. In a fiery PMQs, the Labour leader repeatedly failed to answer the question when asked by a furious Bor…
1,500 experts demand Boris publishes clear plan for schools reopening
In a scathing letter to the prime minister today, UK paediatricians warned the prolonged closure of schools could spark a wave of health, social and educational problems that linger 'long after Covid-19'.
Private schools are offering summer catch-up lessons for state pupils
Six large independent schools - including King's College School Wimbledon (pictured)- are already looking to run their own summer catch-up provision at their own cost.
Teaching unions slammed for 'campaign of fear' over 'death trap' schools
The actions of teaching unions has been described by one MP as 'utterly disgraceful'
Why can children go to Primark but NOT school?', Tory MPs ask unions
Rowing broke out as the heads of the four main teaching unions appeared before the Education Select Committee to discuss the impact of coronavirus on young people.
Marcus Rashford 1-0 Boris Johnson
Manchester United and England striker forces government to act and extend free school meal vouchers over the summer
Racism is ‘bone-deep’ in Britain, says civil rights activist
Civil rights activist Jesse Jackson has called on universities to "include people of colour" as he said racism is "bone-deep" in Britain and the US. The US Baptist minister and politician, who worked with Martin Luther King Jr, spoke out...
Source: https://incomestatements.info
Category: Stock Reports